Vaccine. 2009 Nov 17. [Epub ahead of print]
A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route.
Patel SM, Atmar RL, Sahly HE, Cate TR, Keitel WA. - Baylor...
Announcement
Collapse
No announcement yet.
Search Result
Collapse
3 results in 0.0378 seconds.
Keywords
Members
Tags
-
Giuseppe started a topic Vaccine. A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route.in VaccinesVaccine. A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route.
-
Giuseppe started a topic Vaccine. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.in VaccinesVaccine. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
Vaccine. 2009 Jul 8. [Epub ahead of print]
Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
Zinckgraf JW, Sposato M, Zielinski V, Powell D, Treanor JJ, von Hofe...
-
Giuseppe started a topic Vaccine. Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults.in VaccinesVaccine. Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults.
Vaccine. 2009 Jul 2. [Epub ahead of print]
Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults.
Brady RC, Treanor JJ, Atmar RL, Keitel...